Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential gene expression and AKT targeting in triple negative breast cancer

8 Jul 2019

Abstract excerpt

// Feng-Mao Lin 1 , Susan E. Yost 2 , Wei Wen 3 , Paul H. Frankel 4 , Daniel Schmolze 5 , Pei-Guo Chu 5 , Yate-Ching Yuan 6 , Zheng Liu 6 , John Yim 3 , Zhen Chen 1 and Yuan Yuan 2 1 Department of Diabetes Complications and Metabolism, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA 2 Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Cancer Genomics and Diagnostics
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31320990
DOI: 10.18632/oncotarget.27026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential gene expression and AKT targeting in triple negative breast cancerPMID 31320990Read ↗

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.Semantic proximity Read ↗

Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.Semantic proximity Read ↗

Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review)Semantic proximity Read ↗

A gene transcription signature of the Akt/mTOR pathway in clinical breast tumorsSemantic proximity Read ↗

Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer.Semantic proximity Read ↗

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast CancerSemantic proximity Read ↗

The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast CancerSemantic proximity Read ↗

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)Semantic proximity Read ↗

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted TherapeuticsSemantic proximity Read ↗

Clinicopathogenomic analysis of AKT1-PIK3CA-PTEN-altered luminal metastatic breast cancer in JapanSemantic proximity Read ↗

Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.Semantic proximity Read ↗

A risk signature with two autophagy‐related genes for predicting prognosis of triple negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.